Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain P Thakur, LS Breger, M Lundblad, OW Wan, B Mattsson, KC Luk, ... Proceedings of the National Academy of Sciences 114 (39), E8284-E8293, 2017 | 209 | 2017 |
Inhibition of neuroinflammation and mitochondrial dysfunctions by carbenoxolone in the rotenone model of Parkinson’s disease P Thakur, B Nehru Molecular neurobiology 51, 209-219, 2015 | 80 | 2015 |
Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson’s disease P Thakur, B Nehru Neuroscience 231, 420-431, 2013 | 75 | 2013 |
Long-term heat shock proteins (HSPs) induction by carbenoxolone improves hallmark features of Parkinson's disease in a rotenone-based model P Thakur, B Nehru Neuropharmacology 79, 190-200, 2014 | 53 | 2014 |
Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson’s disease pathology P Thakur, B Nehru Neurochemistry international 75, 1-10, 2014 | 17 | 2014 |
Induction of pulmonary carcinogenesis in Wistar rats by a single dose of 9, 10 dimethylbenz (a) anthracene (DMBA) and the chemopreventive role of diclofenac P Thakur, SN Sanyal Experimental and molecular pathology 88 (3), 394-400, 2010 | 15 | 2010 |
Chemopreventive action of diclofenac in dimethybenzanthracene induced lung cancer in female wistar rat P Thakur, SN Sanyal Journal of Environmental Pathology, Toxicology and Oncology 29 (3), 2010 | 14 | 2010 |
α-Synuclein 2.0—moving towards cell type specific pathophysiology P Thakur, WH Chiu, J Roeper, JA Goldberg Neuroscience 412, 248-256, 2019 | 13 | 2019 |
Are ion channels potential therapeutic targets for Parkinson’s disease? NH Daniel, A Aravind, P Thakur Neurotoxicology 87, 243-257, 2021 | 11 | 2021 |
Chemopreventive role of preferential COX-2 inhibitor diclofenac in 9, 10-dimethybenz (a) anthracene induced experimental lung carcinogenesis P Thakur, SN Sanyal Am J Biomed Sci 2 (3), 275-288, 2010 | 11 | 2010 |
Interaction of alpha-synuclein with lipids N Kachappilly, J Srivastava, BP Swain, P Thakur Methods in Cell Biology 169, 43-66, 2022 | 7 | 2022 |
Selective K-ATP channel-dependent loss of pacemaking in vulnerable nigrostriatal dopamine neurons by α-synuclein aggregates P Thakur, K Luk, J Roeper bioRxiv, 842344, 2019 | 4 | 2019 |
Modeling Parkinson's disease pathology by combined injection of fibrilar and monomeric a-synuclein in rat brain P Thakur, L Breger, M Lundblad, O Wan, B Mattsson, K Luk, V Lee, ... MOVEMENT DISORDERS 32, 2017 | | 2017 |
Pre-formed fibrils injection worsen pathology caused by AAV-mediated over expression of alpha-synuclein LS Breger, P Thakur, OW Wan, B Mattsson, K Luk, VM Lee, J Trojanowski, ... MOVEMENT DISORDERS 31, S235-S235, 2016 | | 2016 |
Speed and severity of toxicity induced by pre-formed a-synuclein fibrils in rat brain is enhanced by a-synuclein overexpression P Thakur, L Breger, B Mattsson, K Luk, MV Lee, J Trojanowski, ... 20th International Congress of Parkinson's Disease and Movement Disorders 31 …, 2016 | | 2016 |
Carbenoxolone Exerts Neuroprotection in an Animal Model of Parkinson's Disease Induced by Proteasome Inhibitor MG-132. A Bhardwaj, P Thakur, B Nehru American Journal of Biomedical Sciences 6 (3), 2014 | | 2014 |
Exploration of molecular targets of sodium salicylate mediating its neuroprotective action in Parkinson's disease P Thakur, B Nehru MOVEMENT DISORDERS 29, S148-S149, 2014 | | 2014 |
Carbenoxolone, a heat shock protein inducer as a therapeutic agent for PD. P Thakur, B Nehru MOVEMENT DISORDERS 27 (4), E5-E6, 2012 | | 2012 |
Unravelling the molecular pathogenesis of Parkinsons disease role of heat shock proteins and oxidative stress P Thakur Chandigarh, 0 | | |